Compounds > zidovudine

Page last updated: 2024-08-23

zidovudine and lodenosine

zidovudine has been researched along with lodenosine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	4 (66.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, S; Barchi, JJ; Driscoll, JS; Ford, H; Kelley, JA; Marquez, VE; Mitsuya, H; Shirasaka, T	1
Baba, M; Balzarini, J; De Clercq, E; Herdewijn, P; Pauwels, R	1
Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV	1
Balzarini, J; De Clercq, E; Knispel, T; Marquez, VE; Meier, C; Siddiqui, MA	1
Bader, JP; Cragg, GM; Newman, DJ; Yang, SS	1
Driscoll, JS; Fridland, A; Hui, FK; Kavlick, MF; Mitsuya, H; Srinivas, RV; Tanaka, M; Ueno, T	1

Reviews

1 review(s) available for zidovudine and lodenosine

Article	Year
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program. Journal of natural products, 2001, Volume: 64, Issue:2 Topics: Amino Acid Sequence; Anti-HIV Agents; HIV-1; Models, Biological; Models, Chemical; Molecular Sequence Data; National Institutes of Health (U.S.); Retrospective Studies; United States; Virus Replication	2001

Other Studies

5 other study(ies) available for zidovudine and lodenosine

Article	Year
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. Journal of medicinal chemistry, 1991, Volume: 34, Issue:5 Topics: Adenosine Deaminase; Antiviral Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV; Kinetics; Prodrugs; Structure-Activity Relationship	1991
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. Journal of medicinal chemistry, 1987, Volume: 30, Issue:11 Topics: Antiviral Agents; Deoxyadenosines; Dideoxyadenosine; HIV; Structure-Activity Relationship	1987
HIV-1 reverse transcriptase inhibitor design using artificial neural networks. Journal of medicinal chemistry, 1994, Aug-05, Volume: 37, Issue:16 Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine	1994
cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade. Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9 Topics: 3T3 Cells; Adenosine Deaminase; AMP Deaminase; Animals; Anti-HIV Agents; Cell Line; Dideoxyadenosine; Drug Delivery Systems; HIV-1; HIV-2; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Mice; Organophosphates; Prodrugs; Structure-Activity Relationship; Virus Replication	1999
In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Animals; Anti-HIV Agents; COS Cells; Deoxyadenine Nucleotides; Dideoxyadenosine; Dideoxynucleotides; Drug Resistance, Microbial; Genes, pol; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine	1997